Literature DB >> 22354556

Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene.

Jessica Ruiz-Medina1, Juan A Flores, Inmaculada Tasset, Isaac Tunez, Olga Valverde, Emilio Fernandez-Espejo.   

Abstract

RATIONALE: Peroxisome proliferator-activated receptors (PPARs) participate in the control of chronic neuropathic and inflammatory pain, and these receptors could play a role on acute pain.
OBJECTIVES: We used null (PPAR-α -/-) and wild-type female mice and the PPAR-α blocker GW6471 to evaluate (1) the role of PPAR-α on neuropathic pain, (2) the involvement of PPAR-α on visceral and acute thermal nociception, and (3) tissue levels of pro-inflammatory factors.
METHODS: Neuropathic pain was induced by sciatic nerve ligature. Acute thermal nociception was evaluated through hot-plate, tail-immersion, and writhing tests. The pro-inflammatory factors nitric oxide, TNF-α, and interleukins-1β and -3 were measured.
RESULTS: Regarding neuropathic pain, higher sensitivity to thermal and mechanical non-noxious and noxious stimuli was observed in mice lacking PPAR-α. Cold and mechanical allodynia and heat hyperalgesia were augmented in null mice. With respect to visceral nociception, writhes after acetic acid were enhanced in mutant mice. Although basal thermal sensitivity was enhanced in PPAR-α -/- mice, cutaneous thermal nociception did not differ between genotypes. Blockade of PPAR-α was devoid of effects on acute thermal and writhing tests. Finally, nerve ligature enhanced pro-inflammatory factors in plantar tissue, levels being higher in null mice. No changes in pro-inflammatory factors were observed in the hot-plate test.
CONCLUSIONS: Genetic ablation of PPAR-α is involved in neuropathic and visceral nociception. Lack of PPAR-α is not involved in acute thermal pain, but it is involved in basal thermal reaction. Changes are biological adaptations to receptor deletion because blockade of PPAR-α does not affect inflammatory pain or thermal reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354556     DOI: 10.1007/s00213-012-2662-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

1.  Heat hyperalgesia following partial sciatic ligation in rats: interacting nature and nurture.

Authors:  Y Shir; Z Seltzer
Journal:  Neuroreport       Date:  2001-03-26       Impact factor: 1.837

Review 2.  PPARs in diseases: control mechanisms of inflammation.

Authors:  Radina Kostadinova; Walter Wahli; Liliane Michalik
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

4.  Anti-nociceptive activity of narcotic agonists and partial agonists in mice given biogenic amines by intracerebroventricular injection.

Authors:  R D Sewell; P S Spencer
Journal:  Psychopharmacologia       Date:  1975-04-30

5.  A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats.

Authors:  Y Shir; Z Seltzer
Journal:  Neurosci Lett       Date:  1990-07-17       Impact factor: 3.046

6.  GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception.

Authors:  Jessica Ruiz-Medina; Catherine Ledent; Olga Valverde
Journal:  Neuropharmacology       Date:  2011-02-23       Impact factor: 5.250

7.  Strain background modifies phenotypes in the ATP8B1-deficient mouse.

Authors:  Sohela Shah; Ukina R Sanford; Julie C Vargas; Hongmei Xu; Annamiek Groen; Coen C Paulusma; James P Grenert; Ludmila Pawlikowska; Saunak Sen; Ronald P J Oude Elferink; Laura N Bull
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

8.  Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans.

Authors:  Ana B Ropero; Pablo Juan-Picó; Alex Rafacho; Esther Fuentes; F Javier Bermúdez-Silva; Enrique Roche; Ivan Quesada; Fernando Rodríguez de Fonseca; Angel Nadal
Journal:  J Endocrinol       Date:  2008-11-18       Impact factor: 4.286

9.  Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia.

Authors:  Bradley K Taylor; Niren Dadia; Carolyn B Yang; Sendhil Krishnan; Mostafa Badr
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

Review 10.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  12 in total

1.  PPARα agonists--an emerging concept in the management of neuropathic and visceral pain.

Authors:  Shailendra Kapoor
Journal:  Psychopharmacology (Berl)       Date:  2012-03-30       Impact factor: 4.530

Review 2.  A lipid gate for the peripheral control of pain.

Authors:  Daniele Piomelli; Andrea G Hohmann; Virginia Seybold; Bruce D Hammock
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.

Authors:  Iryna A Khasabova; Yee Xiong; Lia G Coicou; Daniele Piomelli; Virginia Seybold
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

Review 4.  PPARs and pain.

Authors:  Bright N Okine; Jessica C Gaspar; David P Finn
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

5.  Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.

Authors:  Oscar Sasso; Guillermo Moreno-Sanz; Cataldo Martucci; Natalia Realini; Mauro Dionisi; Luisa Mengatto; Andrea Duranti; Glauco Tarozzo; Giorgio Tarzia; Marco Mor; Rosalia Bertorelli; Angelo Reggiani; Daniele Piomelli
Journal:  Pain       Date:  2012-11-02       Impact factor: 6.961

Review 6.  Peripheral gating of pain signals by endogenous lipid mediators.

Authors:  Daniele Piomelli; Oscar Sasso
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

7.  WY14643 Attenuates the Scopolamine-Induced Memory Impairments in Mice.

Authors:  Hui Xu; Zhengchen You; Zhonghua Wu; Liang Zhou; Jianhong Shen; Zhikai Gu
Journal:  Neurochem Res       Date:  2016-07-16       Impact factor: 3.996

Review 8.  PPAR agonists as therapeutics for CNS trauma and neurological diseases.

Authors:  Shweta Mandrekar-Colucci; Andrew Sauerbeck; Phillip G Popovich; Dana M McTigue
Journal:  ASN Neuro       Date:  2013-12-18       Impact factor: 4.146

Review 9.  Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment.

Authors:  Elizabeth P Moran; Jian-Xing Ma
Journal:  PPAR Res       Date:  2015-01-29       Impact factor: 4.964

10.  PPAR-α acutely inhibits functional activity of ASICs in rat dorsal root ganglion neurons.

Authors:  Jing Wu; Jia-Jia Wang; Ting-Ting Liu; Yi-Mei Zhou; Chun-Yu Qiu; Ding-Wen Shen; Wang-Ping Hu
Journal:  Oncotarget       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.